Molecular Medicine Research Institute
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 1,988,976 | 2,263,574 | −274,598 | -4.1 | 35% |
| 2012 | 4,004,956 | 2,563,467 | 1,441,489 | 3.1 | 36% |
| 2013 | 2,539,406 | 2,688,585 | −149,179 | 2.3 | 39% |
| 2014 | 1,958,639 | 2,806,084 | −847,445 | -1.4 | 10% |
| 2015 | 1,958,433 | 2,831,007 | −872,574 | -5.1 | 11% |
| 2016 | 3,283,682 | 2,879,410 | 404,272 | -3.3 | 9% |
| 2017 | 3,871,444 | 3,240,510 | 630,934 | -0.6 | 8% |
| 2018 | 5,889,157 | 3,592,097 | 2,297,060 | 7.1 | 8% |
| 2019 | 3,529,155 | 3,450,444 | 78,711 | 7.7 | 8% |
| 2020 | 2,911,904 | 3,287,834 | −375,930 | 6.7 | 19% |
| 2021 | 2,796,900 | 3,040,056 | −243,156 | 6.3 | 15% |
| 2022 | 2,786,838 | 2,787,511 | −673 | 6.8 | 33% |
| 2023 | 1,571,099 | 2,888,990 | −1,317,891 | 1.8 | 20% |
In its most recent public year (2023), this organization spent $1,317,891 more than it brought in. Its reserves stood at about 1.8 months of spending, up from -4.1 in 2011. Staff pay was 20% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Molecular Medicine Research Institute's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works